bpc-157 safety evidence clinical trials The FDA is discussing seven peptide-related bulk substances next month: • • KPV • TB-500 • MOTs-C • Emideltide (DSIP) • Semax • Epitalon This is not FDA approval. It is bpc-157 human clinical trial evidence

Therefore, many laboratories advise not to test for these

Perform Better with B12 The most reliable performance signal from B12 supplementation appears when correcting an existing deficiency rather than supplementing on top of adequate baseline

TRIUMPH-4: Efficacy at 68 weeks TRIUMPH-4 (ClinicalTrials.gov identifier NCT05931367) enrolled 445 adults with obesity or overweight plus symptomatic knee osteoarthritis and no type 2 diabetes

Dacquin R, Davey RA, Laplace C, et al

doi:10.3390/molecules191119066 Cerovecki T, Bojanic I, Brcic L, Radic B, Vukoja I, Seiwerth S, Sikiric P

BPC-157 dosing protocols Since BPC-157 isn't an approved drug, there's no official dosing guideline